VALPAS study (EU28)
You are here
23/11/2015
Aim: Feasibility of Colli-Pee™ in HPV-based cervical cancer screening
Coordinator: Novosanis nv
- Colli-Pee™ feasibility assessment in the EU28 and global market
- To assess the potential of Colli-Pee™ collected first-void urine as a user-friendly, non-invasive self-sampling tool in scope of HPV-based cervical cancer screening in the EU
Status: finalized
Publication: Publishable summary